Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Dose Hyperoncotic Serum Albumin for the Treatment of the Acute Phase of Severe Head Injury

NCT00152685 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT00152685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00152685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Dose Hyperoncotic Serum Albumin for the Treatment of the Acute Phase of Severe Head Injury
Lead sponsor
University Hospital, Angers
Phase
Phase 2/3
Overall status
Unknown status
Start date
Not reported
Completion date
Not reported
Enrollment
40
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

severe head injury